Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Davey

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
ACS Infectious Diseases|March 31, 2022
Evaluation of Phenol-Substituted Diphyllin Derivatives as Selective Antagonists for Ebola Virus EntryCaroline B Plescia, Aaron R Lindstrom, Maritza V Quintero, et al.
Journal of Patient-Reported Outcomes|August 10, 2021
Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritisJeffrey R Curtis, Jan Michael Nebesky, Elodie de Bock, et al.
Clinical Pharmacology and Therapeutics|September 4, 2025
Recruiting and Consenting Decentralized Clinical Trial Participants-Learnings from the Trials@Home RADIAL Proof-of-Concept TrialBart Lagerwaard, Linda Rutgrink, Danny van Weelij, et al.
Research Square|February 14, 2024
A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4Robert Davey, Callie Donahue, Aditi Kesari, et al.
Wellcome Open Research|August 2, 2024
COPO - Managing sample metadata for biodiversity: considerations from the Darwin Tree of Life projectFelix Shaw, Alice Minotto, Seanna McTaggart, et al.
Arxiv|June 19, 2020
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, et al.
Plos Pathogens|December 23, 2024
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus InfectionFan Bu, Gang Ye, Kimberly Morsheimer, et al.
ACS Infectious Diseases|September 14, 2016
Evaluation of Ebola Virus Inhibitors for Drug RepurposingPeter B Madrid, Rekha G Panchal, Travis K Warren, et al.
European Journal of Medicinal Chemistry|June 14, 2024
Evaluation of potency and metabolic stability of diphyllin-derived Vacuolar-ATPase inhibitorsLaura M Sanford, Patrick Keiser, Naoaki Fujii, et al.
F1000Research|February 10, 2015
An open science peer review oathJelena Aleksic, Adrian Alexa, Teresa K Attwood, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
ACS Infectious Diseases|March 31, 2022
Evaluation of Phenol-Substituted Diphyllin Derivatives as Selective Antagonists for Ebola Virus EntryCaroline B Plescia, Aaron R Lindstrom, Maritza V Quintero, et al.
Journal of Patient-Reported Outcomes|August 10, 2021
Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritisJeffrey R Curtis, Jan Michael Nebesky, Elodie de Bock, et al.
Clinical Pharmacology and Therapeutics|September 4, 2025
Recruiting and Consenting Decentralized Clinical Trial Participants-Learnings from the Trials@Home RADIAL Proof-of-Concept TrialBart Lagerwaard, Linda Rutgrink, Danny van Weelij, et al.
Research Square|February 14, 2024
A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4Robert Davey, Callie Donahue, Aditi Kesari, et al.
Wellcome Open Research|August 2, 2024
COPO - Managing sample metadata for biodiversity: considerations from the Darwin Tree of Life projectFelix Shaw, Alice Minotto, Seanna McTaggart, et al.
Arxiv|June 19, 2020
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, et al.
Plos Pathogens|December 23, 2024
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus InfectionFan Bu, Gang Ye, Kimberly Morsheimer, et al.
ACS Infectious Diseases|September 14, 2016
Evaluation of Ebola Virus Inhibitors for Drug RepurposingPeter B Madrid, Rekha G Panchal, Travis K Warren, et al.
European Journal of Medicinal Chemistry|June 14, 2024
Evaluation of potency and metabolic stability of diphyllin-derived Vacuolar-ATPase inhibitorsLaura M Sanford, Patrick Keiser, Naoaki Fujii, et al.
F1000Research|February 10, 2015
An open science peer review oathJelena Aleksic, Adrian Alexa, Teresa K Attwood, et al.
Pageof 3